Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites
- 9 July 2008
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 316 (1-2) , 177-186
Abstract
Ubiquitous protein kinase CK2 participates in a variety of key cellular functions. We have explored CK2 involvement in angiogenesis. As shown previously, CK2 inhibition reduced endothelial cell proliferation, survival and migration, tube formation, and secondary sprouting on Matrigel. Intraperitoneally administered CK2 inhibitors significantly reduced preretinal neovascularization in a mouse model of proliferative retinopathy. In this model, CK2 inhibitors had an additive effect with somatostatin analog, octreotide, resulting in marked dose reduction for the drug to achieve the same effect. CK2 inhibitors may thus emerge as potent future drugs aimed at inhibiting pathological angiogenesis. Immunostaining of the retina revealed predominant CK2 expression in astrocytes. In human diabetic retinas, mRNA levels of all CK2 subunits decreased, consistent with increased apoptosis. Importantly, a specific CK2 inhibitor prevented recruitment of bone marrow-derived hematopoietic stem cells to areas of retinal neovascularization. This may provide a novel mechanism of action of CK2 inhibitors on newly forming vessels.Keywords
This publication has 35 references indexed in Scilit:
- Retinal and choroidal microangiopathies: Therapeutic opportunitiesMicrovascular Research, 2007
- Molecular pathways of angiogenesis inhibitionBiochemical and Biophysical Research Communications, 2007
- Combination angiostatic therapy completely inhibits ocular and tumor angiogenesisProceedings of the National Academy of Sciences, 2007
- Is angiogenesis an organizing principle in biology and medicine?Journal of Pediatric Surgery, 2007
- Protein kinase CK2: a newcomer in the ‘druggable kinome’Biochemical Society Transactions, 2006
- Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular NeovascularizationThe American Journal of Pathology, 2006
- Expression of Protein Kinase CK2 in Astroglial Cells of Normal and Neovascularized RetinaThe American Journal of Pathology, 2006
- The shape of things to come: An emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeletonCellular Signalling, 2006
- Involvement of Protein Kinase CK2 in Angiogenesis and Retinal NeovascularizationInvestigative Ophthalmology & Visual Science, 2004
- Hypoxic Regulation of Angiopoietin-2 Expression in Endothelial CellsJournal of Biological Chemistry, 2004